Purpose: Superficial abscesses are a common emergency presentation often requiring surgical admission and management. Ambulatory Care Pathways (ACPs) are a method that can reduce the burden of superficial abscesses on hospital bed pressure by treating superficial abscesses as day cases. We conducted a study to assess the safety and effectiveness of the implementation of an ACP for patients meeting strict criteria presenting out of hours with superficial abscesses. Methodology: The ACP was commenced on June 20th 2021 and data on patients admitted to this pathway was collected for a 12-month period. A control group was created by collecting data of matched patients admitted with superficial abscesses after hours for 12 months beginning 1st July 2019. Data collected included patient demographics, admission times and progression to theatre, inpatient and hospital in the home (HITH) length of stay, as well as any complications, return to theatre or readmissions within 30 days. Results: Both cohorts had similar patient demographics. Inpatient bed days were significantly shorter for ACP patients with a median of 0.30 (IQR 0.20-0.95) days, compared to 1.53 (IQR 1.06-1.70) days for the retrospective cohort (p <0.001). There was no significant difference between the groups when comparing delays to theatre access, numbers of post-operative complications, and rates of 30-day return to theatre and readmission. Conclusion/s: The ACP pathway reduced inpatient length of stay in selected patients presenting out of hours with superficial abscesses and resulted in no increase in patient morbidity.